Blog
RSS FeedPosted by Michael Wonder on 25 Mar 2026
Agenda for the July 2026 PBAC meeting (25 March 2026)
25 March 2026 - The agenda for the July 2026 PBAC meeting is now available. ...
Posted by Michael Wonder on 20 Mar 2026
DUSC utilisation analysis public release documents (October 2025)
20 March 2026 - The utilisation analysis public release documents from the October 2025 DUSC meeting are now available. ...
Posted by Michael Wonder on 20 Mar 2026
Public summary documents (first time decisions not to recommend and deferrals) – November 2025 PBAC meeting
20 March 2026 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the November 2025 PBAC ...
Posted by Michael Wonder on 17 Mar 2026
PBAC advice on equitable access to GLP-1 obesity treatments
17 March 2026 - On 6 March 2025, Minister Butler wrote to the PBAC to request the Committee’s advice on ...
Posted by Michael Wonder on 15 Mar 2026
The end of cancer: how cell therapy breakthroughs have us on the edge of a cure
15 March 2026 - How rapid immunotherapy advancements could relegate killer cancers to the status of a ‘chronic disease’. ...
Posted by Michael Wonder on 10 Mar 2026
Cutting-edge cancer treatment research heading offshore as local patients miss out
11 March 2026 - Newsreader Will McDonald is six years into his fight with aggressive prostate cancer. He wants all Australians ...
Posted by Michael Wonder on 06 Mar 2026
Public summary documents – November 2025 PBAC meeting
6 March 2026 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2025 PBAC ...
Posted by Michael Wonder on 06 Mar 2026
Agenda for the March 2026 PBAC meeting (4 March 2026)
6 March 2026 - The Department of Health has published an updated agenda for the March 2026 PBAC agenda (version ...
Posted by Michael Wonder on 05 Mar 2026
New multi-indication PBS listing for two immunotherapy treatments from March 2026
1 March 2026 - Bristol Myers Squibb Australia confirms that Opdivo (nivolumab) and Yervoy (ipilimumab) will be listed on the ...
Posted by Michael Wonder on 05 Mar 2026
Dying father pleads for cancer drug subsidy to ‘keep being a dad’
5 March 2026 - A North Queensland mother has travelled to Canberra to beg the Federal Government to save her ...
Posted by Michael Wonder on 02 Mar 2026
World first cheaper immunotherapy treatment listing for patients with advanced or rare cancers
1 March 2026 - From today, thousands more Australians living with advanced and rare cancers will have access to affordable ...
Posted by Michael Wonder on 02 Mar 2026
More cheaper medicines to help Australians fight complex and chronic illness
2 March 2026 - Australians living with auto-immune disease, lymphoma, Parkinson's, motor neuron disease and cerebral palsy will have access ...
Posted by Michael Wonder on 02 Mar 2026
Schedule of Pharmaceutical Benefits - 1 March 2026
1 March 2026 - The March 2026 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Mar 2026
New PBS listing for immunotherapy cancer drugs Opdivo and Yervoy to be slashed
2 March 2026 - Patients with advanced and rare cancers will be able to access two immunotherapy drugs for just $25, ...
Posted by Michael Wonder on 21 Feb 2026
Do children get priority in Australia's drug funding decisions?
20 February 2026 - In Australia, the PBAC recommends which medicines should be subsidised through the PBS. ...